Camargo: Camargo Pharmaceutical Services LLC : Patient-Centric Approach and FDA Expertise Lead to Orphan Approval

(marketscreener.com) Challenge An international company developing an orphan drug product needed support navigating the US regulatory process from beginning formulation to NDA approval from a partner with experience in FDA interactions and a deep understanding of the Agency's evolving thinking. Background ...https://www.marketscreener.com/news/latest/Camargo-Pharmaceutical-Services-LLC-nbsp-Patient-Centric-Approach-and-FDA-Expertise-Lead-to-Orphan--35617634/?utm_medium=RSS&utm_content=20210616